USANA Schedules Fourth Quarter and Fiscal Year 2024 Earnings Release and Conference Call
USANA Health Sciences, Inc. (
NYSEUSNA) today announced that fourth quarter and fiscal year 2024 results will be released after the close of market on Tuesday, February 25, 2025. Shortly following the issuance of the Company’s earnings release, the Company will post its Management Commentary document on the Company’s Investor Relations website (http://ir.usana.com) under the News/Events section. USANA will hold a conference call to discuss this announcement with analysts and institutional investors the following morning, Wednesday, February 26, 2025 at 11:00 a.m. Eastern Time.
USANA Health Sciences to Participate in the 27th Annual ICR Conference
USANA Health Sciences, Inc. (
NYSEUSNA), a leading developer and manufacturer of high-quality nutritional supplements, healthy foods and personal care products, today announced that Doug Hekking, Chief Financial Officer, will participate in a fireside chat and host one-on-one meetings with investors at the ICR Conference in Orlando, FL on January 13-14, 2025. The fireside chat will begin at 8:00 AM ET on January 13, 2025.
USANA Health Sciences Announces Strategic Acquisition of Hiya Health
USANA Health Sciences, Inc. (
NYSEUSNA) (the “Company,” “USANA”), today announced its acquisition of a 78.8% controlling ownership stake in Hiya Health Products, LLC (“Hiya”), a leading direct-to-consumer provider of high-quality children’s health & wellness products. The $205 million cash transaction closed on December 23, 2024 and is anticipated to be accretive to USANA’s 2025 adjusted EBITDA. For the last twelve months ended September 30, 2024 (unaudited), Hiya generated net sales of $103 million, net income of $19 million, and adjusted EBITDA of $22 million. As of September 30, 2024, Hiya had more than 200,000 customers.
USANA Health Sciences Reports Third Quarter 2024 Results
USANA Health Sciences, Inc. (
NYSEUSNA) today announced financial results for its fiscal third quarter ended September 28, 2024.
USANA Schedules Third Quarter 2024 Earnings Release and Conference Call
USANA Health Sciences, Inc. (
NYSEUSNA) today announced that third quarter 2024 results will be released after the close of market on Tuesday, October 22, 2024. Shortly following the issuance of the Company’s earnings release, the Company will post its Management Commentary document on the Company’s Investor Relations website (http://ir.usana.com) under the News/Events section. USANA will hold a conference call to discuss this announcement with analysts and institutional investors the following morning, Wednesday, October 23, 2024 at 11:00 a.m. Eastern Time.
USANA Health Sciences Reports Second Quarter 2024 Results
USANA Health Sciences, Inc. (
NYSEUSNA) today announced financial results for its fiscal second quarter ended June 29, 2024.
USANA Schedules Second Quarter 2024 Earnings Release and Conference Call
USANA Health Sciences, Inc. (
NYSEUSNA) today announced that second quarter 2024 results will be released after the close of market on Tuesday, July 23, 2024. Shortly following the issuance of the Company’s earnings release, the Company will post its Management Commentary document on the Company’s Investor Relations website (http://ir.usana.com) under the News/Events section. USANA will hold a conference call to discuss this announcement with analysts and institutional investors the following morning, Wednesday, July 24, 2024 at 11:00 a.m. Eastern Time.
USANA Health Sciences Reports First Quarter 2024 Results
USANA Health Sciences, Inc. (
NYSEUSNA) today announced financial results for its fiscal first quarter ended March 30, 2024.
USANA Schedules First Quarter 2024 Earnings Release and Conference Call
USANA Health Sciences, Inc. (
NYSEUSNA) today announced that first quarter 2024 results will be released after the close of market on Tuesday, April 30, 2024. Shortly following the issuance of the Company’s earnings release, the Company will post its Management Commentary document on the Company’s Investor Relations website (http://ir.usana.com) under the News/Events section. USANA will hold a conference call to discuss this announcement with analysts and institutional investors the following morning, Wednesday, May 1, 2024 at 11:00 a.m. Eastern Time.
USANA Health Sciences Reports Fourth Quarter and Fiscal Year 2023 Results
USANA Health Sciences, Inc. (
NYSEUSNA) today announced financial results for its fiscal fourth quarter and fiscal year ended December 30, 2023.
USANA Schedules Fourth Quarter and Fiscal Year 2023 Earnings Release and Conference Call
USANA Health Sciences, Inc. (
NYSEUSNA) today announced that fourth quarter and fiscal year 2023 results will be released after the close of market on Tuesday, February 6, 2024. Shortly following the issuance of the Company’s earnings release, the Company will post its Management Commentary document on the Company’s Investor Relations website (http://ir.usana.com) under the News/Events section. USANA will hold a conference call to discuss this announcement with analysts and institutional investors the following morning, Wednesday, February 7, 2024 at 11:00 a.m. Eastern Time.
USANA Health Sciences to Participate in the 2024 ICR Conference
USANA Health Sciences, Inc. (
NYSEUSNA), a leading developer and manufacturer of high-quality nutritional supplements, healthy foods and personal care products, today announced that it will host investor meetings and a fireside chat presentation at the ICR Conference in Orlando, FL on January 8-9, 2024. Doug Hekking, Chief Financial Officer, will be participating in the fireside chat, scheduled to begin at 10:30 AM ET on January 8, 2024.
Sidoti Events, LLC's Virtual December Small-Cap ConferenceNEW YORK, NY / ACCESSWIRE / December 5, 2023 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day December Small-Cap Conference taking place Wednesday and Thursday, December 6-7, 2023. The presentation schedule is subject to change. Please visit www.sidoti.com/events for the most updated version and webinar links.
USANA Health Sciences Reports Third Quarter 2023 Results
USANA Health Sciences, Inc. (
NYSEUSNA) today announced financial results for its fiscal third quarter ended September 30, 2023.
USANA Schedules Third Quarter Earnings Release and Conference Call
USANA Health Sciences, Inc. (
NYSEUSNA) today announced that third quarter results will be released after the close of market on Tuesday, October 24, 2023. Shortly following the issuance of the Company’s earnings release, the Company will post its Management Commentary document on the Company’s Investor Relations website (http://ir.usana.com) under the News/Events section. USANA will hold a conference call to discuss this announcement with analysts and institutional investors the following morning, Wednesday, October 25, 2023 at 11:00 a.m. Eastern Time.
USANA Health Sciences Reports Second Quarter Net Sales of $238 Million and Diluted EPS of $0.89
USANA Health Sciences, Inc. (
NYSEUSNA) today announced financial results for its fiscal second quarter ended July 1, 2023.
USANA Schedules Second Quarter Earnings Release and Conference Call
USANA Health Sciences, Inc. (
NYSEUSNA) today announced that second quarter results will be released after the close of market on Tuesday, July 25, 2023. Shortly following the issuance of the Company’s earnings release, the Company will post its Management Commentary document on the Company’s Investor Relations website (http://ir.usana.com) under the News/Events section. USANA will hold a conference call to discuss this announcement with analysts and institutional investors the following morning, Wednesday, July 26, 2023 at 11:00 a.m. Eastern Time.
USANA Health Sciences Announces Plans to Expand into India
USANA Health Sciences, Inc. (
NYSEUSNA) today announced its plans to expand into India in the second half of 2023. Expansion into India increases the Company’s global footprint to 25 markets.
USANA Health Sciences Inc. (NYSE: USNA) Making Surprising Moves in Wednesday SessionUSANA Health Sciences, Inc. (
NYSEUSNA) has caught the attention of the investment community today with its bullish price action. The company’s shares are currently up 8.24% on the day to $67.77.
USANA Health Sciences Reports First Quarter Net Sales of $248 Million and Diluted EPS of $0.95
USANA Health Sciences, Inc. (
NYSEUSNA) today announced financial results for its fiscal first quarter ended April 1, 2023.
USANA Schedules First Quarter Earnings Release and Conference Call
USANA Health Sciences, Inc. (
NYSEUSNA) today announced that first quarter results will be released after the close of market on Tuesday, April 25, 2023. Shortly following the issuance of the Company’s earnings release, the Company will post its Management Commentary document on the Company’s Investor Relations website (http://ir.usana.com) under the News/Events section. USANA will hold a conference call to discuss this announcement with analysts and institutional investors the following morning, Wednesday, April 26, 2023 at 11:00 a.m. Eastern Time.
USANA Health Sciences to Participate in Upcoming Investor Conferences
USANA Health Sciences, Inc. (
NYSEUSNA), a leading developer and manufacturer of high-quality nutritional supplements, healthy foods and personal care products, today announced that Doug Hekking, Chief Financial Officer, is scheduled to participate in upcoming investor conferences.
USANA Health Sciences Announces CEO Transition Plan
USANA Health Sciences, Inc. (
NYSEUSNA) today announced that consistent with the Company’s planned succession strategy, Kevin Guest, USANA’s Chief Executive Officer (CEO) since 2015 and Chairman of the Board since 2020, will transition to the role of Executive Chairman of the Company, effective July 1, 2023. At that time, Jim Brown, USANA’s current President, will be named CEO of the Company.
USANA Health Sciences Reports Fourth Quarter and Fiscal Year 2022 Results
USANA Health Sciences, Inc. (
NYSEUSNA) today announced financial results for its fiscal fourth quarter and full year ended December 31, 2022.
USANA Health Sciences Provides Preliminary Fiscal Year 2022 Results and Issues Initial Fiscal Year 2023 Outlook
USANA Health Sciences, Inc. (
NYSEUSNA) today announced preliminary fiscal year 2022 results and initial guidance for fiscal year 2023 ahead of its presentation at the 25th Annual ICR Conference.
